Sfoglia per Autore
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE
2026 Peccatori, N; Curto, A; Silvestri, D; Rebellato, S; Antic, Z; Bhatia, S; Bergmann, A; Borkhardt, A; Zimmermann, M; Strehl, S; Nebral, K; Saitta, C; Quadri, M; Palmi, C; Bardini, M; Guardo, D; Lo Nigro, L; Parasole, R; Putti, M; Locatelli, F; Alten, J; Stanulla, M; Valsecchi, M; Buldini, B; Conter, V; Biondi, A; Balduzzi, A; Schrappe, M; Attarbaschi, A; Cario, G; Rizzari, C; Cazzaniga, G; Fazio, G
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge
2026 Balduzzi, A; Valsecchi, M; Tran, T; Zuna, J; Leoni, V; Cario, G; Fazio, G; Gandemer, V; Tasian, S; Van Der Sluis, I; Peccatori, N; Parasole, R; Monterisi, S; Loh, M; Devidas, M; Hunger, S; Kairalla, J; De Lorenzo, P; Silverman, L; Biondi, A
"Per aspera ad astra": the transformative contribution of glucarpidase to the improved management of delayed methotrexate elimination after high-dose therapy
2026 Peccatori, N; Schwartz, S; Rizzari, C
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases
2025 Peccatori, N; Coppola, M; Colombini, A; Silvestri, D; Bertorello, N; Kiren, V; Melchionda, F; Mura, R; Onofrillo, D; Gobbi, S; Mattera, R; Vinti, L; Casini, T; Santoro, N; Sperli, D; D'Ippolito, C; Conter, V; Biondi, A; Rizzari, C
Case Report: Post-splenectomy bulky pelvic splenosis in an adolescent with hereditary spherocytosis
2025 Di Majo, B; Peccatori, N; Inzoli, A; Degrate, L; Jaconi, M; Ratti, M; Casiraghi, A; Ferrari, G; Sala, D; Biondi, A; Passoni, P; Corti, P
Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injury
2025 Peccatori, N; Ardissino, G; Cesaro, S; Danesi, R; Gaspari, S; Meazza, C; Mura, R; Rizzari, C
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials
2025 Peccatori, N; Brivio, E; Lissat, A; Bautista Sirvent, F; Salzer, E; Biondi, A; Fazio, G; Rizzari, C; Tasian, S; Zwaan, C
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
2025 Peccatori, N; Di Majo, B; Claut, L; Colombini, A; Gotti, G; Leoni, V; Lucchini, G; Sala, A; Spinelli, M; Balduzzi, A; Rizzari, C; Bettini, L
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence
2024 Peccatori, N; Chiocca, E; Conter, V; Tondo, A; Marzorati, M; Casini, T; Veltroni, M; Biondi, A; Fazio, G
WORDS OF WISDOM: ONCOHAEMATOLOGY THROUGH CLINICAL CASES
2024 Peccatori, N; Limido, F; Faraguna, M; Dagri, A; Coslovich, S; Marchettini, E; Rocco, E; Tessitore, A; Biondi, A
Clinical Management of Philadelphia Chromosome-Positive and ABL-Class Fusion-Positive Acute Lymphoblastic Leukemia
2024 Tran, T; Leoni, V; Peccatori, N; Silverman, L; Biondi, A
LEMIERRE SYNDROME: A CASE REPORT
2024 Gibellato, E; Petrela, S; Arosio, A; Peccatori, N; Melzi, M; Lazzerotti, A; Biondi, A
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua
2018 Peccatori, N; Ortiz, R; Rossi, E; Calderon, P; Conter, V; García, Y; Biondi, A; Espinoza, D; Ceppi, F; Mendieta, L; Melzi, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile